DGAP-Adhoc: Constantin Medien AG: Business performance in

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
DGAP-Adhoc: Constantin Medien AG: Business performance in the third quarter 2013 below expectations - guidance for 2013 adjusted

Constantin Medien AG / Key word(s): Profit Warning 06.11.2013 17:09 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Constantin Medien AG: Business performance in the third quarter 2013 below expectations - guidance for 2013 adjusted Ismaning, November 6, 2013 - The business performance of Constantin Medien AG fell significantly short of own expectations in the third quarter 2013. In the Sports Segment, the increased investments in program and production could not yet be monetarised, despite the considerable increase in market share. Also lower than expected advertising revenues had a negative impact on results. Furthermore, the Film Segment with its international film titles could not match the very successful third quarter last year. As a consequence, preliminary Group sales stand at EUR 116.3 million in the third quarter 2013, 26.9 percent below the previous year's level (EUR 159.1 million). Thereby, it should be noted that the third quarter 2012 was a strong quarter regarding sales and earnings. Preliminary profit from operations (EBIT) in the third quarter 2013 amounts to EUR -3.3 million (Q3 2012: EUR 9.1 million); preliminary Group earnings after taxes (earnings attributable to shareholders) amount to EUR -5.9 million (Q3 2012: EUR -0.9 million). Due to the below-budget performance in the third quarter, the Management Board is anticipating that the 2013 full-year objective of Group sales of EUR 440 million to EUR 480 million and positive Group earnings attributable to shareholders can no longer be reached. Assuming no unforeseeable events of material significance for the Group occur, the Management Board instead is assuming Group sales of EUR 430 million to EUR 450 million and negative Group earnings attributable to shareholders. The interim financial report as of September 30, 2013 of Constantin Medien AG will be published on November 12, 2013. About Constantin Medien AG: ISIN: DE0009147207, DE000A1EWS01, DE000A1R07C3 WKN: 914720, A1EWS0, A1R07C Listed: Regulated Market (Prime Standard) in Frankfurt, Regulated unofficial market of Frankfurt stock exchange, Regulated unofficial market Berlin, Duesseldorf, Hamburg, Munich, Stuttgart Contact PR: Constantin Medien AG, Sabine Lais, Phone: +49 (0) 89 99 500 461, Fax: +49 (0) 89 99 500 466 Frank Elsner Kommunikation für Unternehmen GmbH, Phone: +49 (0) 5404 91 92 0, Fax: +49 (0) 5404 91 92 29 Contact IR: Constantin Medien AG, Dr Peter Braunhofer, Phone: +49 (0) 89 99 500 436, Fax: +49 (0) 89 99 500 433 Constantin Medien AG Muenchener Strasse 101g, 85737 Ismaning, Registered Office: Ismaning Phone: +49 (0) 89 99 500 0, Fax: +49 (0) 89 99 500 111 06.11.2013 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: Constantin Medien AG Münchener Stra�e 101 g 85737 Ismaning Germany Phone: 089 / 99500-436 Fax: 089 / 99500-433 E-mail: ir@constantin-medien.de Internet: http://www.constantin-medien.de ISIN: DE0009147207, DE000A0GQKR4, DE000A1R07C3 WKN: 914720, A0GQKR, A1R07C Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, Düsseldorf, Hamburg, München, Stuttgart End of Announcement DGAP News-Service ---------------------------------------------------------------------------

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Sales Focus Inc. Awarded as Leading Medical Outsourcing Service

Updated Category News Views 112

Sales Focus Inc.: Leading the Way in Healthcare Outsourcing Sales Focus Inc. (SFI) proudly announces its recognition as the Top Healthcare and Medical Sales Outsourcing Service for 2025. This prestigious accolade showcases the company's vital role in revolutionizing the healthcare sector with its innovative full-lifecycle sales execution model and robust industry...

Continue Reading
The Rise of Autonomous Data Platforms in the Tech Industry

Updated Category News Views 76

Exploring the Autonomous Data Platform Market Growth The world of data management is rapidly evolving, with the Autonomous Data Platform Market projected to reach an impressive USD 14.96 billion by 2032. This explosive growth expands at a significant CAGR of 27.89% from its current valuation, representing a fundamental shift in how organizations interact with their data....

Continue Reading
Enpro's Recent Insider Activity Signals Strong Future Potential

Updated Category News Views 177

Insider Purchase by William Abbey at Enpro In the latest SEC filing, the market received noteworthy news about Enpro. William Abbey, who serves as a Director at Enpro (NYSE:NPO), demonstrated significant confidence in the company by purchasing 567 shares for a total of $139,997. What This Purchase Indicates This insider transaction suggests a strong belief in Enpro's...

Continue Reading
Massive Increase in BNB Fund for Cancer Patients Unveiled

Updated Category News Views 168

BNB Donation Achieves Remarkable Growth Recently, an incredible story surfaced about the untouched donation made in BNB (CRYPTO: BNB) for cancer patients. This donation, originally valued at $200,000, has soared to an astonishing $39 million thanks to the surging market value of cryptocurrencies, particularly BNB. Impact of Cryptocurrency Fluctuation on Charity Funds...

Continue Reading
Bio X Cell Refreshes Brand Identity to Enhance Global Research Impact

Updated Category News Views 171

Bio X Cell Unveils a Fresh Brand Identity Bio X Cell, recognized as the global leader in functional antibodies tailored for in vivo and emerging preclinical models, has introduced a modernized brand identity. This change is a testament to nearly three decades of excellence in the field, seamlessly merging scientific innovation with expanding global capabilities in...

Continue Reading